North America Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography) and End User (Hospitals & Clinics, Ambulatory Surgical Centers,

North America Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography) and End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialized Eye Care Centers, and Other End Users)

The North America retinal imaging devices market is expected to reach US$ 936.7 million by 2028 from US$ 629.0 million in 2021. The market is estimated to grow at a CAGR of 5.9% from 2021 to 2028.

The growing prevalence of diabetes has resulted in the rising prevalence of diabetic retinopathy and blindness in adults. According to the International Diabetes Federation (IDF) data for 2021, nearly 537 million adults (between 20 and 79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. 3 in 4 adults with diabetes live in low- and middle-income countries. The report by IDF also stated the maximum portion of people in most countries is suffering from type 2 diabetes. Nearly 79% of the people who have type 2 diabetes are living in low and middle-income countries. Thus, owing to the projections and statistics by IDF, diabetic retinopathy is expected to become a major eye health condition or disease over the next few years.

The COVID-19 pandemic perplexed healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from eye disease treatment to COVID-19 diagnosis and treatment devices led to a decline in market growth to a certain extent. Retinal surgical patients require vital ICU resources and have also been potentially in the risk category of complications of COVID-19. The sustained efficacy of retinal disorder treatment depends on repeated and regular treatment until disease activity has ceased. However, most hospitals and surgical centers have considered canceling or postponing elective surgeries, including retinal surgeries, due to the pandemic situation.

Moreover, market players also witnessed disruption in their business operations, and slumped demand for products had a marginally negative impact on the North America retinal imaging devices market. Hence, the COVID 19 had a somewhat negative effect on the market before the introduction of the COVID-19 vaccine. However, in the long run, as the vaccination schedule has been established and the transmission rate decreases, healthcare systems are expected to return to normal and experience increased demand for retinal imaging devices during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America retinal imaging devices market at a substantial CAGR during the forecast period.

North America Retinal Imaging Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Retinal Imaging Devices Market Segmentation

By Device Type

Fluorescein Angiography Fundus Camera Optical Coherence Tomography By End User

Hospitals & Clinics Ambulatory Surgical Centers Specialized Eye Care Centers Other End Users By Country

North America US Canada Mexico Companies Mentioned

Carl Zeiss Meditec Revenio Group Oyj Nikon Corporation Optomed Topcon Corporation Imagine Eyes Epipole Ltd Forus Health Pvt Ltd Eyenuk Inc. Phoenix Technology Group Llc

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America retinal imaging devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America retinal imaging devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.